Association of free radicals and the tissue renin-angiotensin system: Prospective effects of Rhodiola, a genus of Chinese herb, on hypoxia-induced pancreatic injury

Journal of the Pancreas

Volumn 2, Issue 1, 2001, Pages 16-25

  Ip, Siu Po ^a   Che, Chun Tao ^a   Leung, Po Sing ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antioxidants; Chinese traditional; Medicine; Medicine, herbal; Oxidants; Pancreas; Pancreatic diseases; Reactive oxygen species; Receptors, angiotensin

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPHENYLIODONIUM SALT; FREE RADICAL; LOSARTAN; MESSENGER RNA; OXYGEN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RENIN; RHODIOLA EXTRACT; XANTHINE OXIDASE; HERBACEOUS AGENT;

ALTITUDE DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; CELL FUNCTION; CHINESE HERB; CHINESE MEDICINE; DRUG MECHANISM; ELECTROLYTE BALANCE; ENZYME ACTIVATION; HORMONE ACTION; HYPOXIA; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN DIFFUSION; PANCREAS FUNCTION; PANCREAS INJURY; PATHOPHYSIOLOGY; POLYCYTHEMIA; PROTEIN EXPRESSION; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TISSUE DISTRIBUTION; ANIMAL; ANOXIA; ANTIBODY SPECIFICITY; HUMAN; METABOLISM; METHODOLOGY; PANCREAS; PATHOLOGY; PHYSIOLOGY; PHYTOTHERAPY; PROSPECTIVE STUDY; REVIEW; RHODIOLA;

ANIMALS; ANOXIA; DRUGS, CHINESE HERBAL; FREE RADICALS; HUMANS; ORGAN SPECIFICITY; PANCREAS; PHYTOTHERAPY; PROSPECTIVE STUDIES; RENIN-ANGIOTENSIN SYSTEM; RHODIOLA;

EID: 0035240452     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Tigerstedt R, Bergmann P. Niere und Kreislauf. Scand Arch Physiol 1898; 8:223-71.
2. Stroth U, Unger T. The renin-angiotensin system and its receptors. J Cardiovasc Pharmacol 1999; 33(Suppl. 1):S21-8. [99151408]
3. Davis GK, Roberts DH. Molecular genetics of the renin-angiotensin system: implications for angiotensin II receptor blockade. Pharmacol Ther 1997; 75:43-50.
4. Regitz-Zagrosek V, Friedel N, Heymann A, Bauer P, Neuss M, Rolfs A, et al. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995; 91:1461-71.
5. Regitz-Zagrosek V, Neuss M, Warnecke C, Holzmeister J, Hildebrandt AG, Fleck E. Subtype 2 and atypical angiotensin receptors in the human heart. Basic Res Cardiol 1996; 91(Suppl. 2):73-7.
6. Campbell DJ. Circulating and tissue angiotensin systems. J Clin Invest 1987; 79:1-6.
7. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988; 77:I4-13. [88223736]
8. Unger T, Gohlke P, Paul M, Rettig R. Tissue renin-angiotensin systems: fact or fiction?. J Cardiovasc Pharmacol 1991; 18(Suppl. 2):S20-5.
9. Danser AH. Local renin-angiotensin systems. Mol Cell Biochem 1996; 157:211-6.
10. Chappell MC, Diz DI, Jacobsen DW. Pharmacological characterization of angiotensin II binding sites in the canine pancreas. Peptides 1992; 13:313-8. [93027675]
11. Leung PS, Chan WP, Wong TP, Sernia C. Expression and localization of the renin-angiotensin system in the rat pancreas. J Endocrinol 1999; 160:13-9. [99077887]
12. Phillips MI, Speakman EA, Kimura B. Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 1993; 43:1-20. [93150166]
13. Chan WP, Fung ML, Nobiling R, Leung PS. Activation of local renin-angiotensin system by chronic hypoxia in rat pancreas. Mol Cell Endocrinol 2000; 160:107-14. [20181765]
14. Costa LE, Llesuy S, Boveris A. Active oxygen species in the liver of rats submitted to chronic hypobaric hypoxia. Am J Physiol 1993; 264:C1395-400.
15. Coulter CV, Kelso GF, Lin TK, Smith RA, Murphy MP. Mitochondrially targeted antioxidants and thiol reagents. Free Radic Biol Med 2000; 28:1547-54.
16. Shan XQ, Aw TY, Jones DP. Glutathione-dependent protection against oxidative injury. Pharmacol Ther 1990; 47:61-71.
17. Giugliano D. Dietary antioxidants for cardiovascular prevention. Nutr Metab Cardiovas 2000; 10:38-44.
18. Mates JM, Perez-Gomez C, Nunez de CI. Antioxidant enzymes and human diseases. Clin Biochem 1999; 32:595-603.
19. Mates JM, Sanchez-Jimenez F. Antioxidant enzymes and their implications in pathophysiologic processes. Front Biosci 1999; 4:D339-45.
20. Sies H. Glutathione and its role in cellular functions. Free Radic Biol Med 1999; 27:916-21. [20034912]
21. Chan AC. Partners in defense, vitamin E and vitamin C. Can J Physiol Pharmacol 1993; 71:725-31.
22. Griffith OW. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic Biol Med 1999; 27:922-35.
23. Yoshikawa T, Furukawa Y, Wakamatsu Y, Takemura S, Tanaka H, Kondo M. Experimental hypoxia and lipid peroxide in rats. Biochem Med 1982; 27:207-13.
24. Zhang H, Schmeisser A, Garlichs CD, Plotze K, Damme U, Mugge A, Daniel WG. Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases. Cardiovasc Res 1999; 44:215-22. [20082267]
25. El Bassiouni EA, Abo-Ollo MM, Helmy MH, Ismail S, Ramadan MI. Changes in the defense against free radicals in the liver and plasma of the dog during hypoxia and/or halothane anaesthesia. Toxicology 1998; 128:25-34.
26. Shan X, Aw TY, Smith ER, Ingelman-Sundberg M, Mannervik B, Iyanagi T, Jones DP. Effect of chronic hypoxia on detoxication enzymes in rat liver. Biochem Pharmacol 1992; 43:2421-6. [92304369]
27. Costa LE. Hepatic cytochrome P-450 in rats submitted to chronic hypobaric hypoxia. Am J Physiol 1990; 259:C654-9.
28. Gillespie MN, Kojima S, Owasoyo JO, Tai HH, Jay M. Hypoxia provokes leukotriene-dependent neutrophil sequestration in perfused rabbit hearts. J Pharmacol Exp Ther 1987; 241:812-6.
29. Arnould T, Michiels C, Remacle J. Increased PMN adherence on endothelial cells after hypoxia: involvement of PAF, CD18/CD11b, and ICAM-1. Am J Physiol 1993; 264:C1102-10.
30. Bougelet C, Roland IH, Ninane N, Arnould T, Remacle J, Michiels C. Effect of aescine on hypoxia-induced neutrophil adherence to umbilical vein endothelium. Eur J Pharmacol 1998; 345:89-95.
31. Kantrow SP, Huang YC, Whorton AR, Grayck EN, Knight JM, Millington DS, Piantadosi CA. Hypoxia inhibits nitric oxide synthesis in isolated rabbit lung. Am J Physiol 1997; 272:L1167-73.
32. Whorton AR, Simonds DB, Piantadosi CA. Regulation of nitric oxide synthesis by oxygen in vascular endothelial cells. Am J Physiol 1997; 272:L1161-6.
33. Granger DN. Cell adhesion and migration. II. Leukocyte-endothelial cell adhesion in the digestive system. Am J Physiol 1997; 273:G982-6. [98042106]
34. Lefer AM, Lefer DJ. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion. Cardiovasc Res 1996; 32:743-51.
35. Panes J, Granger DN. Leukocyte-endothelial cell interactions: molecular mechanisms and implications in gastrointestinal disease. Gastroenterology 1998; 114:1066-90.
36. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990; 87:1620-4. [90160378]
37. 2. interaction. J Biol Chem 1997; 272:9922-32. [97248545]
38. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995; 268:L699-722.
39. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxidedependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996; 271:40-7. [96132880]
40. Wood JG, Johnson JS, Mattioli LF, Gonzalez NC. Systemic hypoxia promotes leukocyte-endothelial adherence via reactive oxidant generation. J Appl Physiol 1999; 87:1734-40.
41. Zhong Z, Arteel GE, Connor HD, Yin M, Frankenberg MV, Stachlewitz RF, et al. Cyclosporin A increases hypoxia and free radical production in rat kidneys: prevention by dietary glycine. Am J Physiol 1998; 275:F595-604. [98431937]
42. Saugstad OD. Role of xanthine oxidase and its inhibitor in hypoxia: reoxygenation injury. Pediatrics 1996; 98:103-7.
43. 2-dependent types of rat liver xanthine dehydrogenase. J Biol Chem 1989; 264:10015-22.
44. Nishino T, Nishino T, Schopfer LM, Massey V. The reactivity of chicken liver xanthine dehydrogenase with molecular oxygen. J Biol Chem 1989; 264:2518-27.
45. Nishino T. The conversion of xanthine dehydrogenase to xanthine oxidase and the role of the enzyme in reperfusion injury. J Biochem (Tokyo) 1994; 116:1-6. [95096003]
46. 2-dependent form (type O). Arch Biochem Biophys 1976; 172:365-79.
47. Radeke HH, Cross AR, Hancock JT, Jones OT, Nakamura M, Kaever V, Resch K. Functional expression of NADPH oxidase components (alpha- and betasubunits of cytochrome b558 and 45-kDa flavoprotein) by intrinsic human glomerular mesangial cells. J Biol Chem 1991; 266:21025-9.
48. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 1994; 74:1141-8.
49. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 1993; 91:2546-51.
50. Jaimes EA, Galceran JM, Raij L. Angiotensin II induces superoxide anion production by mesangial cells. Kidney Int 1998; 54:775-84.
51. Griendling KK, Rittenhouse SE, Brock TA, Ekstein LS, Gimbrone MA Jr., Alexander RW. Sustained diacylglycerol formation from inositol phospholipids in angiotensin II-stimulated vascular smooth muscle cells. J Biol Chem 1986; 261:5901-6.
52. Brock TA, Rittenhouse SE, Powers CW, Ekstein LS, Gimbrone MA Jr., Alexander RW. Phorbol ester and 1-oleoyl-2-acetylglycerol inhibit angiotensin activation of phospholipase C in cultured vascular smooth muscle cells. J Biol Chem 1985; 260:14158-62.
53. Regitz-Zagrosek V, Neuss M, Holzmeister J, Warnecke C, Fleck E. Molecular biology of angiotensin receptors and their role in human cardiovascular disease. J Mol Med 1996; 74:233-51.
54. Ohara Y, Peterson TE, Zheng B, Kuo JF, Harrison DG. Lysophosphatidylcholine increases vascular superoxide anion production via protein kinase C activation. Arterioscler Thromb 1994; 14:1007-13.
55. Agwu DE, McPhail LC, Sozzani S, Bass DA, McCall CE. Phosphatidic acid as a second messenger in human polymorphonuclear leukocytes. Effects on activation of NADPH oxidase. J Clin Invest 1991; 88:531-9.
56. Berry C, Hamilton CA, Brosnan MJ, Magill FG, Berg GA, McMurray JJ, Dominiczak AF. Investigation into the sources of superoxide in human blood vessels: angiotensin II increases superoxide production in human internal mammary arteries. Circulation 2000; 101:2206-12. [20263651]
57. Warnholtz A, Nickenig G, Schulz E, Macharzina R, Brasen JH,. Skatchkov M, et al. Increased NADH-oxidase-mediated superoxide production in the early stages of atherosclerosis: evidence for involvement of the renin-angiotensin system. Circulation 1999; 99:2027-33. [99225407]
58. Hannken T, Schroeder R, Stahl RA, Wolf G. Angiotensin II-mediated expression of p27Kip1 and induction of cellular hypertrophy in renal tubular cells depend on the generation of oxygen radicals. Kidney Int 1998; 54:1923-33.
59. Zafari AM, Ushio-Fukai M, Akers M, Yin Q, Shah A, Harrison DG, et al. Role of NADH/NADPH oxidasederived H2O2 in angiotensin II-induced vascular hypertrophy. Hypertension 1998; 32:488-95. [98413202]
60. Guzik TJ, West NE, Black E, McDonald D, Ratnatunga C, Pillai R, Channon KM. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000; 86:E85-90. [20270563]
61. Dimmeler S, Rippmann V, Weiland U, Haendeler J, Zeiher AM. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997; 81:970-6.
62. Walter DH, Haendeler J, Galle J, Zeiher AM, Dimmeler S. Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria. Circulation 1998; 98:1153-7.
63. 2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995; 95:651-7.
64. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995; 92:10663-7. [96068676]
65. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 1996; 27:760-5.
66. 1 receptors. J Biol Chem 1996; 271:22729-35. [96394341]
67. 2 receptor inhibits proliferation and promotes differentiation in PC12W cells. Mol Cell Endocrinol 1996; 122:59-67.
68. Gallinat S, Csikos T, Meffert S, Herdegen T, Stoll M, Unger T. The angiotensin AT2 receptor downregulates neurofilament M in PC12W cells. Neurosci Lett. 1997; 227:29-32. [97322197]
69. Lindpaintner K, Ganten D. The cardiac renin-angiotensin system. An appraisal of present experimental and clinical evidence. Circ Res 1991; 68:905-21.
70. Wiseman N, Ellis A. Fundamentals of Chinese medicine. Massachusetts: Paradigm Publications, 1996.
71. Ming HQ, Xia GC, Zheng RZ. Advanced research on Rhodiola. Chinese Herb Med 1988; 19:229-34.
72. Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine 2000; 7:85-9.
73. Rege NN, Thatte UM, Dahanukar SA. Adaptogenic properties of six rasayana herbs used in Ayurvedic medicine. Phytother Res 1999; 13:275-91.
74. Kurmukov AG, Aizikov MI, Rakhimov SS. Pharmacology of the plant polyphenol epigalokhin. Farmakol Toksikol 1986; 49:45-8.
75. Azizov AP, Seifulla RD. The effect of elton, leveton, fitoton and adapton on the work capacity of experimental animals. Eksp Klin Farmakol 1998; 61:61-3.
76. Tezuka Y, Fan W, Kasimu R, Kadota S. Screening of crude drug extracts for prolyl endopeptidase inhibitory activity. Phytomedicine 1999; 6:197-203.
77. Fan W, Tezuka Y, Komatsu K, Namba T, Kadota S. Prolyl endopeptidase inhibitors from the underground part of Rhodiola sacra S. H. Fu. Biol Pharm Bull 1999; 22:157-61.
78. Peng JN, Ge YC, Li XH. Studies on the chemical constituents of Rhodiola fastigita. Acta Pharmaceut Sin 1996; 31:798-800.
79. Lishmanov I, Naumova AV, Afanas'ev SA, Maslov LN. Contribution of the opioid system to realization of inotropic effects of Rhodiola rosea extracts in ischemic and reperfusion heart damage in vitro. Eksp Klin Farmakol 1997; 60:34-6.
80. Zhang Z, Wang L, Chen Q, Feng S, Cao Z, Zhou X, et al, Electron microscopic observation of the effects of Rhodiola kirilowii (Regel.) Maxim. in preventing damage of the rat viscera by a hypoxic high altitude environment. China Journals of Chinese Materia Medica 1990; 15:177-81.
81. Hongjingtian. In Zheng HZ, Dong ZH, She J, eds. Modern Study of Traditional Chinese Medicine. Volume 6. 1st ed. Beijing: Beijing Xue Yuan Press, 1997: 5658-78.
82. Ohsugi M, Fan W, Hase K, Xiong Q, Tezuka Y, Komatsu K, et al. Active-oxygen scavenging activity of traditional nourishing-tonic herbal medicines and active constituents of Rhodiola sacra. J Ethnopharmacol 1999; 67:111-9.
83. Xi AQ, Zhang XS, Lu XM. Effect of Sanpu Hongjingtian (Rhodiola sp) capsule on erythrocyte deformability and oxygen free radical in patients with high altitude polycythemia. Chinese Traditional and Herbal Drugs 2000; 442-4.